Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Wolff

Showing results (121-130 of 177) with videos related to

Pageof 18
Sort By:
Transplantation and Cellular Therapy|May 23, 2025
NIH Chronic Graft-Versus-Host Disease Consensus Conference 2025 UpdateStephanie J Lee, Kirsten M Williams, Stefanie Sarantopoulos, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 6, 2010
Consensus Conference on Clinical Practice in Chronic GVHD: Second-Line Treatment of Chronic Graft-versus-Host DiseaseDaniel Wolff, Michael Schleuning, Stephanie von Harsdorf, et al.
International Journal of Immunogenetics|July 26, 2018
The influence of glucocorticoid receptor single nucleotide polymorphisms on outcome after haematopoietic stem cell transplantationJean Norden, Kim F Pearce, Julie A E Irving, et al.
Bone Marrow Transplantation|June 7, 2018
EBMT-NIH-CIBMTR Task Force position statement on standardized terminology & guidance for graft-versus-host disease assessmentHelene M Schoemans, Stephanie J Lee, James L Ferrara, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 19, 2025
Sustained allogeneic kidney graft operational tolerance despite discontinued conventional immunosuppression after CD19-CAR-T cell therapy for relapsed/refractory posttransplant lymphoproliferative disorderHelena Hansmann, Chiara Henkel, Matthias A Fante, et al.
Ejhaem|August 25, 2020
Coronavirus disease 2019 induces multi-lineage, morphologic changes in peripheral blood cellsFlorian Lüke, Evelyn Orsó, Jana Kirsten, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 5, 2014
Metagenomic analysis of the stool microbiome in patients receiving allogeneic stem cell transplantation: loss of diversity is associated with use of systemic antibiotics and more pronounced in gastrointestinal graft-versus-host diseaseErnst Holler, Peter Butzhammer, Karin Schmid, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 17, 2019
Changes in Immunosuppressive Treatment of Chronic Graft-versus-Host Disease: Comparison of 2 Surveys within Allogeneic Hematopoietic Stem Cell Transplant Centers in Germany, Austria, and SwitzerlandDaniel Wolff, Inken Hilgendorf, Eva Wagner-Drouet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 26, 2010
Allogeneic hematopoietic stem-cell transplantation in patients with hematologic malignancies after dose-escalated treosulfan/fludarabine conditioningJochen Casper, Daniel Wolff, Wolfgang Knauf, et al.
Transplantation and Cellular Therapy|March 17, 2022
High Mortality of COVID-19 Early after Allogeneic Stem Cell Transplantation: A Retrospective Multicenter Analysis on Behalf of the German Cooperative Transplant Study GroupJudith Schaffrath, Christina Brummer, Daniel Wolff, et al.
Pageof 18

Showing results (121-130 of 177) with videos related to

Sort By:
Pageof 18
Transplantation and Cellular Therapy|May 23, 2025
NIH Chronic Graft-Versus-Host Disease Consensus Conference 2025 UpdateStephanie J Lee, Kirsten M Williams, Stefanie Sarantopoulos, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 6, 2010
Consensus Conference on Clinical Practice in Chronic GVHD: Second-Line Treatment of Chronic Graft-versus-Host DiseaseDaniel Wolff, Michael Schleuning, Stephanie von Harsdorf, et al.
International Journal of Immunogenetics|July 26, 2018
The influence of glucocorticoid receptor single nucleotide polymorphisms on outcome after haematopoietic stem cell transplantationJean Norden, Kim F Pearce, Julie A E Irving, et al.
Bone Marrow Transplantation|June 7, 2018
EBMT-NIH-CIBMTR Task Force position statement on standardized terminology & guidance for graft-versus-host disease assessmentHelene M Schoemans, Stephanie J Lee, James L Ferrara, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 19, 2025
Sustained allogeneic kidney graft operational tolerance despite discontinued conventional immunosuppression after CD19-CAR-T cell therapy for relapsed/refractory posttransplant lymphoproliferative disorderHelena Hansmann, Chiara Henkel, Matthias A Fante, et al.
Ejhaem|August 25, 2020
Coronavirus disease 2019 induces multi-lineage, morphologic changes in peripheral blood cellsFlorian Lüke, Evelyn Orsó, Jana Kirsten, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 5, 2014
Metagenomic analysis of the stool microbiome in patients receiving allogeneic stem cell transplantation: loss of diversity is associated with use of systemic antibiotics and more pronounced in gastrointestinal graft-versus-host diseaseErnst Holler, Peter Butzhammer, Karin Schmid, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 17, 2019
Changes in Immunosuppressive Treatment of Chronic Graft-versus-Host Disease: Comparison of 2 Surveys within Allogeneic Hematopoietic Stem Cell Transplant Centers in Germany, Austria, and SwitzerlandDaniel Wolff, Inken Hilgendorf, Eva Wagner-Drouet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 26, 2010
Allogeneic hematopoietic stem-cell transplantation in patients with hematologic malignancies after dose-escalated treosulfan/fludarabine conditioningJochen Casper, Daniel Wolff, Wolfgang Knauf, et al.
Transplantation and Cellular Therapy|March 17, 2022
High Mortality of COVID-19 Early after Allogeneic Stem Cell Transplantation: A Retrospective Multicenter Analysis on Behalf of the German Cooperative Transplant Study GroupJudith Schaffrath, Christina Brummer, Daniel Wolff, et al.
Pageof 18